This item is authorised by the following title:
For a transitional provision relating to the repeal of this instrument, see section 38 of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021).
Replacement date 31 October 2016
These were the documents as published
For a transitional provision relating to the repeal of this instrument, see section 38 of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021).